Literature DB >> 12899993

Enantiomeric resolution of some 2-arylpropionic acids using L-(-)-serine-impregnated silica as stationary phase by thin layer chromatography.

Hassan Y Aboul-Enein1, Mahmoud I El-Awady, Charles M Heard.   

Abstract

The enantiomeric resolution of certain 2-arylpropionic acids was achieved on thin silica gel plates impregnated with optically pure L-(-)-serine as chiral selector. The mobile phase enabling successful resolution of (+/-)-ibuproxam and (+/-)-ketoprofen was acetonitrile-methanol-water (16:4:0.5, v/v/v) and (16:3:0.5, v/v/v) for (+/-)-tiaprofenic acid. The spots were detected with iodine vapors and the detection limits were found to be different for each of the 2-arylpropionic acid, ranging between 0.25 and 0.50 microg/ml. The effect of concentration of the impregnating chiral selector, temperature and pH on resolution has been studied. The procedure was applied successfully to resolve commercial ampoules of ketoprofen dosage formulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12899993     DOI: 10.1016/s0731-7085(03)00208-5

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Validated stability indicating methods for determination of nitazoxanide in presence of its degradation products.

Authors:  Nouruddin W Ali; Samah Sayed Abbas; Hala El-Sayed Zaazaa; Maha Mohamed Abdelrahman; Mohamed Abdelkawy
Journal:  J Pharm Anal       Date:  2011-11-30

2.  Micelle enhanced fluorimetric and thin layer chromatography densitometric methods for the determination of (+/-) citalopram and its S-enantiomer escitalopram.

Authors:  Elham A Taha; Nahla N Salama; Shudong Wang
Journal:  Anal Chem Insights       Date:  2009-04-07

3.  Validated Densitometric TLC-Method for the Simultaneous Analysis of (R)- and (S)-Citalopram and its Related Substances Using Macrocyclic Antibiotic as a Chiral Selector: Application to the Determination of Enantiomeric Purity of Escitalopram.

Authors:  Suzan Mahmoud Soliman
Journal:  Int J Biomed Sci       Date:  2012-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.